FDA Clearance Tracker · K083199
CHARTIS CONSOLE
Last checked: Nov 19, 2026Latest source record: Jun 25, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2009
Substantially Equivalent
Time to decision
238 days
Received Oct 30, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K083199
- Device name
- CHARTIS CONSOLE
- Applicant
- Pulmonx, Inc.
- Applicant location
- Palo Alto, CA
- Received
- Oct 30, 2008
- Decided
- Jun 25, 2009
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Spirometer, Diagnostic (BZG)
- Device class
- Class II
- Regulation
- 21 CFR 868.1840
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code BZG. The earliest in FDA's data is K770927, decided May 26, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K083199
- The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Pulmonx, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.